AJJ — Asian American Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual income statement for Asian American Medical, fiscal year end - August 31st, SGD millions except per share, conversion factor applied.

	2018 August 31st	R2019 August 31st	2020 August 31st	R2021 August 31st	2022 August 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	PRESS	ARS
Standards:	IFRS	IFRS	IFRS	—	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	17.5	7.67	4.82	1.24	0.808
Cost of Revenue
Gross Profit	7.11	3.37	1.07	0.659	0.355
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	16	9.8	7.49	6.82	1.58
Operating Profit	1.49	-2.12	-2.67	-5.58	-0.771
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1.9	-2.03	-2.58	-5.65	-0.79
Provision for Income Taxes
Net Income After Taxes	2.07	-2.03	-2.58	-5.65	-0.79
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	1.95	-2.05	-2.46	-5.86	-0.79
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1.95	-2.05	-2.46	-5.86	-0.79
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.003	-0.006	-0.015	-0.017	-0.002